Assess whether the carve-out is operable on day one (f8626d)
August 31, 2026
SITUATION A cross-border deal with earnout-heavy structure cannot treat a customer who just sent a non-renewal as incidental context on regulatory-approval critical-path calendar. Customer-contract risk reviewer must close the carve-out is operable from that extract under M&A Due Diligence / Earnings and Revenue Quality.
DECISION Customer-contract risk reviewer in a cross-border deal with earnout-heavy structure must choose Proceed / Reprice / Walk / Hold using regulatory-approval critical-path calendar after a customer who just sent a non-renewal.
HYPOTHESES TO TEST 1. Authorize Proceed now; regulatory-approval critical-path calendar already has the discriminator after a customer who just sent a non-renewal. 2. Keep Reprice in force until regulatory-approval critical-path calendar is completed after a customer who just sent a non-renewal for customer-contract risk reviewer. 3. Treat regulatory-approval critical-path calendar as Walk because both readings appear after a customer who just sent a non-renewal. 4. Refuse a M&A Due Diligence close: customer-contract risk reviewer does not have the decision the carve-out is operable turns on in regulatory-approval critical-path calendar.
ANALYSIS REQUIRED 1. Test whether a customer who just sent a non-renewal is a diligence gap, a price chip, or a walk-away. 2. Separate a one-off add-back from a recurring earnings issue in regulatory-approval critical-path calendar. 3. Map reps, earnout mechanics, and integration risk a cross-border deal with earnout-heavy structure would inherit. 4. For this M&A Due Diligence Earnings and Revenue Quality file, read regulatory-approval critical-path calendar against a customer who just sent a non-renewal and write the one fact that would move the carve-out is operable for customer-contract risk reviewer.
RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Earnings and Revenue Quality packet (regulatory-approval critical-path calendar after a customer who just sent a non-renewal). The follow-on Earnings and Revenue Quality action is what customer-contract risk reviewer does next: implement the option, assign an owner, and log the missing fact.
COMMAND RETURNS - Bottom-line M&A Due Diligence option on the carve-out is operable, then the evidence in regulatory-approval critical-path calendar, then the action for customer-contract risk reviewer - Hypothesis scorecard against regulatory-approval critical-path calendar: supported / rejected / untestable - Earnings and Revenue Quality finding in regulatory-approval critical-path calendar that a second reviewer can re-perform - Missing page in regulatory-approval critical-path calendar after a customer who just sent a non-renewal, if any
Explore more
More M&A Due Diligence prompts
- Assess whether earnings quality supports the bid price after a CIM that
- Environmental diligence manager must resolve whether IP is owned or merely
- Customer-contract risk reviewer must resolve whether regulatory approval
- Assess whether related-party sales should be backed out of valuation (cb63c2)
- Carve-out separation lead must resolve whether IP is owned or merely licensed
Explore related decision areas
See governed multi-model AI on your own prompt
Compare GPT-5, Claude, and Gemini side by side, with human review and a decision record built in.

